<DOC>
	<DOCNO>NCT02204579</DOCNO>
	<brief_summary>This open-label study look effect NPSP795 ( selective calcium receptor antagonist ) activate mutation Calcium-sensing receptor patient Autosomal Dominant Hypocalcemia . Patients ADH low blood calcium level inappropriately increase renal calcium excretion , decrease renal phosphate excretion , hyperphosphatemia . PTH blood calcium level test IV infusion NPSP795 . Concentrations NPSP795 length time IV infusion vary depend measure level ionize calcium .</brief_summary>
	<brief_title>A Study Determine Effects NPSP795 Calcium-sensing Receptor Subjects With Autosomal Dominant Hypocalcemia Measured PTH Levels Blood Calcium Concentrations</brief_title>
	<detailed_description />
	<mesh_term>Hypocalcemia</mesh_term>
	<criteria>Subjects heterozygous activate mutation CaSR gene ( ADH ) ; previously confirm , genetic testing perform screening visit At least 18 year age Body mass index ( BMI ) â‰¥ 18.5 &lt; 39 kg/m2 Diseases condition might compromise major body system interfere pharmacokinetics NPSP795 History treatment PTH 184 134 within previous 6 month History hypocalcemia require frequent IV calcium infusion History hypocalcemic seizure within past 3 month Blood 25hydroxy vitamin D level &lt; 25 ng/mL . If subject blood 25hydroxy vitamin D level &lt; 25 ng/mL outpatient screen visit , prescribe vitamin D replacement . Once 25hydroxy vitamin D level &gt; 25 ng/mL , subject eligible continue treatment phase study Estimated glomerular filtration rate ( GFR ) &lt; 25 mL/minute , and/or abnormal hepatic , hematologic , and/or clot function 12 lead rest electrocardiogram ( ECG ) clinically significant abnormality Concomitant medication potential interfere NPSP795 metabolism History thyroid parathyroid surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Autosomal Dominant Hypocalcemia</keyword>
	<keyword>Hypocalcemia</keyword>
	<keyword>ADH</keyword>
	<keyword>Hypoparathyroidism</keyword>
</DOC>